Literature DB >> 23134613

Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis.

J T Marchesan1, T Morelli, S K Lundy, Y Jiao, S Lim, N Inohara, G Nunez, D A Fox, W V Giannobile.   

Abstract

Periodontitis is a polymicrobial oral infection characterized by the destruction of tooth-supporting structures that can be linked to systemic diseases such as cardiovascular disease, diabetes or rheumatoid arthritis. Porphyromonas gingivalis, a bacterium implicated in the etiology of periodontitis, has shown variation in inducing T-cell responses among different strains. Therefore, in this study we investigated the strain-specific immune response using a murine experimental model of periodontitis. Periodontitis was induced by P. gingivalis strains A7A1-28, W83 and W50, and later confirmed by the presence of P. gingivalis in the oral microflora and by alveolar bone resorption. Splenocytes were evaluated for gene expression, cellular proteins and cytokine expression. Dendritic cells were stimulated in vitro for T helper cell-cytokine profiling. Results showed that P. gingivalis had the ability to alter the systemic immune response after bacterial exposure. Strains W50 and W83 were shown to induce alveolar bone loss, whereas the A7A1-28 strain did not significantly promote bone resorption in mice. Splenocytes derived from mice infected with strains W50 and W83 induced expression of high levels of interleukin-4 (IL-4) but A7A1-28 stimulated increased IL-10. Stimulation of dendritic cells in vitro showed a similar pattern of cytokine expression of IL-12p40, IL-6 and transforming growth factor-β among strains. A distinct systemic response in vivo was observed among different strains of P. gingivalis, with IL-10 associated with the least amount of alveolar bone loss. Evaluation of pathogen-driven systemic immune responses associated with periodontal disease pathogenesis may assist in defining how periodontitis may impact other diseases.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134613      PMCID: PMC4106254          DOI: 10.1111/omi.12001

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  42 in total

1.  P. gingivalis-specific T-cell lines produce Th1 and Th2 cytokines.

Authors:  E Gemmell; C L Carter; D A Grieco; P B Sugerman; G J Seymour
Journal:  J Dent Res       Date:  2002-05       Impact factor: 6.116

2.  Underestimation of periodontitis in NHANES surveys.

Authors:  Jasim M Albandar
Journal:  J Periodontol       Date:  2011-01-07       Impact factor: 6.993

3.  Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair.

Authors:  Chan Ho Park; Zachary R Abramson; Mario Taba; Qiming Jin; Jia Chang; Jaclynn M Kreider; Steven A Goldstein; William V Giannobile
Journal:  J Periodontol       Date:  2007-02       Impact factor: 6.993

4.  Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.

Authors:  J Katz; K P Black; S M Michalek
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 5.  Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints.

Authors:  G P Garlet
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

6.  Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.

Authors:  Steven K Lundy; Dov L Boros
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.

Authors:  K F Hoffmann; A W Cheever; T A Wynn
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

8.  T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice.

Authors:  Hajime Sasaki; Noriyuki Suzuki; Ralph Kent; Nobuyuki Kawashima; Junji Takeda; Philip Stashenko
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 9.  Periodontitis in systemic rheumatic diseases.

Authors:  Paola de Pablo; Iain L C Chapple; Christopher D Buckley; Thomas Dietrich
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

10.  The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease.

Authors:  Vincent E Friedewald; Kenneth S Kornman; James D Beck; Robert Genco; Allison Goldfine; Peter Libby; Steven Offenbacher; Paul M Ridker; Thomas E Van Dyke; William C Roberts
Journal:  J Periodontol       Date:  2009-07       Impact factor: 6.993

View more
  11 in total

Review 1.  Mobile microbiome: oral bacteria in extra-oral infections and inflammation.

Authors:  Y W Han; X Wang
Journal:  J Dent Res       Date:  2013-04-26       Impact factor: 6.116

2.  Distinctive pathways characterize A. actinomycetemcomitans and P. gingivalis.

Authors:  Jing Lv; Yi-Xin Zhu; Ying-Qun Liu; Xin Xue
Journal:  Mol Biol Rep       Date:  2014-10-29       Impact factor: 2.316

3.  The in vivo T helper type 17 and regulatory T cell immune responses to Aggregatibacter actinomycetemcomitans.

Authors:  S Mahabady; N Tjokro; S Aharonian; H H Zadeh; C Chen; H Allayee; P P Sedghizadeh
Journal:  Mol Oral Microbiol       Date:  2017-06-27       Impact factor: 3.563

4.  Polymicrobial oral conventionalization model in mice.

Authors:  Maria Imaculada de Queiroz Rodrigues; Camila Carvalho de Oliveira Coelho; Fabrício Bitu Sousa; Lidiany Karla Azevedo Rodrigues Gerage; Mário Rogério Lima Mota; Ana Paula Negreiros Nunes Alves
Journal:  Braz J Microbiol       Date:  2022-03-04       Impact factor: 2.214

Review 5.  Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences.

Authors:  Gena D Tribble; Jennifer E Kerr; Bing-Yan Wang
Journal:  Future Microbiol       Date:  2013-05       Impact factor: 3.165

6.  Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis.

Authors:  Julie Teresa Marchesan; Elizabeth Ann Gerow; Riley Schaff; Andrei Dan Taut; Seung-Yun Shin; James Sugai; David Brand; Aaron Burberry; Julie Jorns; Steven Karl Lundy; Gabriel Nuñez; David A Fox; William V Giannobile
Journal:  Arthritis Res Ther       Date:  2013-11-12       Impact factor: 5.156

7.  Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis.

Authors:  Indra Sandal; Anastasios Karydis; Jiwen Luo; Amanda Prislovsky; Karen B Whittington; Edward F Rosloniec; Chen Dong; Deborah V Novack; Piotr Mydel; Song Guo Zheng; Marko Z Radic; David D Brand
Journal:  Arthritis Res Ther       Date:  2016-10-26       Impact factor: 5.156

8.  Effects by periodontitis on pristane-induced arthritis in rats.

Authors:  Kaja Eriksson; Erik Lönnblom; Gregory Tour; Anna Kats; Piotr Mydel; Pierre Georgsson; Catharina Hultgren; Nastya Kharlamova; Ulrika Norin; Jörgen Jönsson; Anna Lundmark; Annelie Hellvard; Karin Lundberg; Leif Jansson; Rikard Holmdahl; Tülay Yucel-Lindberg
Journal:  J Transl Med       Date:  2016-11-03       Impact factor: 5.531

Review 9.  Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer's disease.

Authors:  Ingar Olsen; Martin A Taubman; Sim K Singhrao
Journal:  J Oral Microbiol       Date:  2016-11-22       Impact factor: 5.474

10.  Porphyromonas gingivalis within Placental Villous Mesenchyme and Umbilical Cord Stroma Is Associated with Adverse Pregnancy Outcome.

Authors:  Sizzle F Vanterpool; Jasper V Been; Michiel L Houben; Peter G J Nikkels; Ronald R De Krijger; Luc J I Zimmermann; Boris W Kramer; Ann Progulske-Fox; Leticia Reyes
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.